From Wikipedia, the free encyclopedia
Cerebral edema or cerebral
œdema is an excess accumulation of water in the
intracellular and/or extracellular spaces of the brain.
Types
Four types of cerebral
edema have been
distinguished[1]:
(1) Vasogenic cerebral
edema
Due to a breakdown of tight endothelial junctions which make up
the blood-brain barrier (BBB). This
allows normally excluded intravascular proteins and fluid to
penetrate into cerebral parenchymal extracellular space. Once
plasma constituents cross the BBB, the edema spreads; this may be
quite fast and widespread. As water enters white matter it moves
extracellularly along fiber tracts and can also affect the gray
matter. This type of edema is seen in response to trauma, tumors,
focal inflammation, late stages of cerebral ischemia and hypertensive encephalopathy.
Some of the mechanisms contributing to BBB dysfunction are:
physical disruption by arterial hypertension or trauma,
tumor-facilitated release of vasoactive and endothelial destructive
compounds (e.g. arachidonic acid, excitatory neurotransmitters,
eicosanoids, bradykinin, histamine and free radicals). Some of the
special subcategories of vasogenic edema include:
Hydrostatic cerebral
edema
-
- This form of cerebral edema is seen in acute, malignant
hypertension. It is thought to result from direct transmission of
pressure to cerebral capillary with transudation of fluid into the
ECF from the capillaries.
Cerebral edema from brain
cancer
-
- Cancerous glial
cells (glioma) of the
brain can increase secretion of vascular endothelial
growth factor (VEGF) which weakens the junctions of the blood-brain
barrier. Dexamethasone can be of benefit in
reducing VEGF secretion[2].
High Altitude Cerebral
Edema
-
- High altitude cerebral
edema (or HACE) is a severe form of
(sometimes fatal) altitude sickness. HACE is the result
of swelling of brain tissue from leakage of fluids from the
capillaries due to the effects of hypoxia on the mitochondria-rich endothelial cells of the blood-brain
barrier[3].
-
- Symptoms can include headache, loss of coordination (ataxia),
weakness, and decreasing levels of consciousness including
disorientation, loss of memory, hallucinations, psychotic behavior,
and coma. It generally occurs after a week or more at high altitude.
Severe instances can lead to death if not treated quickly.
Immediate descent is a necessary life-saving measure (2,000 - 4,000
feet). There are some medications (e.g. dexamethasone) that may be prescribed for
treatment in the field, but these require proper medical training
in their use. Anyone suffering from HACE must be evacuated to a
medical facility for proper follow-up treatment. A gamow bag can sometimes be
used to stabilize the sufferer before transport or descending.
-
- Climbers may also suffer high altitude pulmonary
edema (HAPE), which affects the lungs. While not
as life threatening as HACE in the initial stages, failure to
descend to lower altitudes or receive medical treatment can also
lead to death.
(2) Cytotoxic cerebral
edema
In this type of edema the BBB remains intact. This edema is due
to the derangement in cellular metabolism resulting in inadequate
functioning of the sodium and potassium pump in the glial cell membrane. As a
result there is cellular retention of sodium and water. There are
swollen astrocytes in gray and white matter. Cytoxotic edema is
seen with various intoxications (dinitrophenol,
triethyltin, hexachlorophene, isoniazid), in Reye's syndrome, severe hypothermia, early ischemia, encephalopathy,
early stroke or hypoxia,
cardiac arrest, pseudotumor cerebri, and cerebral toxins.
(3) Osmotic cerebral
edema
Normally cerebral-spinal fluid (CSF) and extracellular fluid
(ECF) osmolality of the brain is slightly greater than that of
plasma. When plasma is diluted by excessive water intake (or hyponatremia), syndrome of inappropriate antidiuretic
hormone secretion (SIADH), hemodialysis, or rapid reduction of blood
glucose in hyperosmolar hyperglycemic state (HHS), formerly
hyperosmolar non-ketotic acidosis (HONK), the brain osmolality will
then exceed the serum osmolality creating an abnormal pressure
gradient down which water will flow into the brain causing
edema.
(4) Interstitial cerebral
edema
Occurs in obstructive hydrocephalus. This form of edema is due
to rupture of CSF-brain barrier resulting in trans-ependymal flow
of CSF; this permits CSF to penetrate brain and spread in the
extracellular space of white matter. Differentiated from vasogenic
edema in that fluid contains almost no protein
Treatment
Treatment approaches can include mannitol, diuretics and surgical decompression .[4]
References
- ^
Qureshi AI, Suarez JI (2000). "Use
of hypertonic saline solutions in treatment of cerebral edema and
intracranial hypertension" (HTML).
Critical Care Medicine 28 (9): 3301–3313.
doi:10.1097/00003246-200009000-00032. PMID 11008996.
- ^
Heiss JD, Papavassiliou E, Merrill
MJ, Nieman L, Knightly JJ, Walbridge S, Edwards NA, Oldfield EH
(1996). "Mechanism of dexamethasone
suppression of brain tumor-associated vascular permeability in
rats. Involvement of the glucocorticoid receptor and vascular
permeability factor" (HTML).
Journal of Clinical Investigation 98 (6):
1400–1408. doi:10.1172/JCI118927.
PMID 8823305. http://www.jci.org/articles/view/118927.
- ^
Van Osta A, Moraine JJ, Mélot C,
Mairbäurl H, Maggiorini M, Naeije R (2005). "Effects of high altitude
exposure on cerebral hemodynamics in normal subjects" (HTML). STROKE
36 (3): 557–560. doi:10.1161/01.STR.0000155735.85888.13. PMID 15692117. http://stroke.ahajournals.org/cgi/content/full/36/3/557.
- ^ Raslan A, Bhardwaj A (2007). "Medical
management of cerebral edema". Neurosurgical focus
22 (5): E12. doi:10.3171/foc.2007.22.5.13. PMID 17613230.
External
links
|
Pathology of the nervous system, primarily CNS (G04–G47,
323–349) |
|
|
Inflammation |
|
|
Brain/
encephalopathy |
|
|
|
|
|
|
autoimmune
( Multiple
sclerosis, Neuromyelitis optica, Schilder's
disease) · hereditary
( Adrenoleukodystrophy, Alexander,
Canavan, Krabbe, ML, PMD, VWM, MFC,
CAMFAK
syndrome) · Central pontine
myelinolysis · Marchiafava-Bignami
disease · Alpers'
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
Spinal cord/
myelopathy |
|
|
|
Both/either |
|
|
| central nervous system navs:
anat/physio/dev, noncongen/congen/neoplasia,
symptoms+signs/eponymous, proc |
|